Ctt Pharmaceutical Holdings Stock Probability of Future Pink Sheet Price Finishing Under 0.065

CTTH Stock  USD 0.06  0.01  8.95%   
CTT Pharmaceutical's future price is the expected price of CTT Pharmaceutical instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of CTT Pharmaceutical Holdings performance during a given time horizon utilizing its historical volatility. Check out CTT Pharmaceutical Backtesting, CTT Pharmaceutical Valuation, CTT Pharmaceutical Correlation, CTT Pharmaceutical Hype Analysis, CTT Pharmaceutical Volatility, CTT Pharmaceutical History as well as CTT Pharmaceutical Performance.
  
Please specify CTT Pharmaceutical's target price for which you would like CTT Pharmaceutical odds to be computed.

CTT Pharmaceutical Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CTT Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CTT Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
CTT Pharmaceutical is way too risky over 90 days horizon
CTT Pharmaceutical has some characteristics of a very speculative penny stock
CTT Pharmaceutical appears to be risky and price may revert if volatility continues
CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0.
CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations.

CTT Pharmaceutical Technical Analysis

CTT Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. CTT Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CTT Pharmaceutical Holdings. In general, you should focus on analyzing CTT Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

CTT Pharmaceutical Predictive Forecast Models

CTT Pharmaceutical's time-series forecasting models is one of many CTT Pharmaceutical's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CTT Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about CTT Pharmaceutical

Checking the ongoing alerts about CTT Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CTT Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
CTT Pharmaceutical is way too risky over 90 days horizon
CTT Pharmaceutical has some characteristics of a very speculative penny stock
CTT Pharmaceutical appears to be risky and price may revert if volatility continues
CTT Pharmaceutical has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0.
CTT Pharmaceutical Holdings currently holds about 32.12 K in cash with (145.16 K) of positive cash flow from operations.

Other Information on Investing in CTT Pink Sheet

CTT Pharmaceutical financial ratios help investors to determine whether CTT Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CTT with respect to the benefits of owning CTT Pharmaceutical security.